SpringWorks Therapeutics, Inc. Share Price
Stocks
SWTX
US85205L1070
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.99 USD | +0.02% |
|
-.--% | - |
| 15/12 | Immunome jumps after promising results for its desmoid tumor treatment | |
| 01/12 | Tyra Bioscience Appoints Bhavesh Ashar as Chief Operating Officer | MT |
| Market Cap | 354.06Cr 310.44Cr 286.16Cr 267.9Cr 502.36Cr 33TCr 512.79Cr 3.44TCr 1.33TCr 17TCr 1.33TCr 1.3TCr 57TCr | P/E 2023 |
-7.09x | P/E 2024 | -10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 308.66Cr 270.64Cr 249.47Cr 233.55Cr 437.95Cr 29TCr 447.04Cr 3TCr 1.16TCr 14TCr 1.16TCr 1.13TCr 50TCr | EV / Sales 2023 |
36,25,07,725x | EV / Sales 2024 | 1,16,54,155x |
| Free-Float |
97.93% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +0.02% |
| 1 year | 46.98 | 47.01 | |
| 3 years | 18 | 62 | |
| 5 years | 13.6 | 89.75 | |
| 10 years | 13.6 | 96.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 01/01/2023 | |
Joe Zimmerman
CMP | Compliance Officer | - | 01/01/2022 |
Kim Diamond
IRC | Investor Relations Contact | - | 01/08/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/25/01 | Issuer sale | General Counsel | 3,97,427 | 0.5304% | ||
| 01/25/01 | Issuer sale | Chief Technology Officer | 3,69,000 | 0.4924% | ||
| 01/25/01 | Issuer sale | Director | 85,011 | 0.1134% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.02% | -.--% | -.--% | +92.66% | 354.06Cr | ||
| +2.06% | +3.76% | +21.48% | -19.31% | 6.31TCr | ||
| +0.74% | +3.52% | +53.14% | +219.37% | 5.56TCr | ||
| -3.10% | +34.30% | +34.30% | +34.30% | 4.16TCr | ||
| -2.36% | -1.25% | -52.13% | -58.98% | 3.9TCr | ||
| +6.97% | +9.89% | +70.21% | -23.28% | 2.98TCr | ||
| +12.59% | +5.18% | +144.26% | -44.13% | 2.37TCr | ||
| +5.78% | +15.81% | +60.64% | +80.73% | 2.15TCr | ||
| -1.25% | -1.31% | -4.39% | +142.42% | 1.69TCr | ||
| -0.81% | +5.91% | +67.70% | +124.13% | 1.67TCr | ||
| Average | +2.06% | +5.11% | +39.52% | +54.79% | 3.11TCr | |
| Weighted average by Cap. | +1.75% | +5.35% | +37.18% | +47.88% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 5.45 4.78 4.4 4.12 7.73 513.83 7.89 52.91 20.47 253.95 20.45 20.01 880.57 | 191.59 167.99 154.84 144.97 271.83 18.07T 277.48 1.86T 720.14 8.93T 719.42 703.71 30.97T |
| Net income | -33Cr -29Cr -26Cr -25Cr -46Cr -3.07TCr -47Cr -315.81Cr -122.2Cr -1.52TCr -122.08Cr -119.41Cr -5.26TCr | -26Cr -23Cr -21Cr -20Cr -37Cr -2.44TCr -37Cr -250.75Cr -97Cr -1.2TCr -97Cr -95Cr -4.17TCr |
| Net Debt | -66Cr -57Cr -53Cr -50Cr -93Cr -6.18TCr -95Cr -636.79Cr -246.4Cr -3.06TCr -246.15Cr -240.78Cr -11TCr | -45Cr -40Cr -37Cr -34Cr -64Cr -4.28TCr -66Cr -441.02Cr -170.65Cr -2.12TCr -170.48Cr -166.76Cr -7.34TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SWTX Stock
Select your edition
All financial news and data tailored to specific country editions
















